Construction and validation of a neovascular glaucoma nomogram in patients with diabetic retinopathy after pars plana vitrectomy

Table 2 Logistic regression analysis of postoperative neovascular glaucoma in patients with diabetic retinopathy

Variables	β	SE	Wald χ2	P value	OR (95%CI)
Posterior capsular integrity in combined cataract surgery	2.474	1.045	5.608	0.018	11.868 (1.532-91.953)
Ipilateral carotid artery stenosis ≤ 25.0%	1.202	1.33	0.817	0.366	3.328 (0.245-45.148)
Residual retinal non-perfusion area	1.505	1.087	1.918	0.166	4.504 (0.535-37.904)
Preoperative VEGF	0.047	0.018	6.844	0.009	1.048 (1.012-1.086)
HbA1c	0.689	0.267	6.678	0.010	1.992 (1.181-3.361)
Aqueous IL-6	0.101	0.036	8.135	0.004	1.107 (1.032-1.186)
Aqueous IL-10	0.756	0.240	9.959	0.002	2.130 (1.332-3.406)
Aqueous TNF-α	0.304	0.466	0.426	0.514	1.356 (0.543-3.382)
Constant	-35.565	8.211	18.76	< 0.001	-

NVG: Neovascular glaucoma; DR: Diabetic retinopathy; VEGF: Vascular endothelial growth factor; HbAlc: Glycosylated hemoglobin; IL-6: Interleukin-6; IL-10: Interleukin-10; TNF-α: Tumor necrosis factor alpha.